Title : Policy-induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia - Fisher_2019_Pharmacoepidemiol.Drug.Saf_28_1067 |
Author(s) : Fisher A , Carney G , Bassett K , Maclure KM , Dormuth CR |
Ref : Pharmacoepidemiol Drug Safety , 28 :1067 , 2019 |
Abstract : |
PubMedSearch : Fisher_2019_Pharmacoepidemiol.Drug.Saf_28_1067 |
PubMedID: 31267629 |
Title : Comparison of cholinesterase inhibitor safety in real-world practice - Carney_2019_Alzheimers.Dement.(N.Y)_5_732 |
Author(s) : Carney G , Bassett K , Wright JM , Maclure M , McGuire N , Dormuth CR |
Ref : Alzheimers Dement (N Y) , 5 :732 , 2019 |
Abstract : |
PubMedSearch : Carney_2019_Alzheimers.Dement.(N.Y)_5_732 |
PubMedID: 31921965 |
Title : Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching - Fisher_2017_Drugs.Aging_34_221 |
Author(s) : Fisher A , Carney G , Bassett K , Dormuth CR |
Ref : Drugs & Aging , 34 :221 , 2017 |
Abstract : |
PubMedSearch : Fisher_2017_Drugs.Aging_34_221 |
PubMedID: 28138912 |
Title : Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation - Fisher_2016_Value.Health_19_688 |
Author(s) : Fisher A , Carney G , Bassett K , Chappell NL |
Ref : Value Health , 19 :688 , 2016 |
Abstract : |
PubMedSearch : Fisher_2016_Value.Health_19_688 |
PubMedID: 27565287 |